| P2093 | author name string | Peng Li | |
| | Jinliang Xu | |
| | Haibo Ma | |
| | Baoxing Liu | |
| | Dongfeng Yuan | |
| | Guanghui Liang | |
| | Wenqun Xing | |
| P2860 | cites work | miR-130b-3p/301b-3p negatively regulated Rb1cc1 expression on myogenic differentiation of chicken primary myoblasts | Q47909062 |
| | Declaration of Helsinki, 2008: implications for stakeholders in research | Q49160916 |
| | Signaling pathways activated by the phytochemical nordihydroguaiaretic acid contribute to a Keap1-independent regulation of Nrf2 stability: Role of glycogen synthase kinase-3. | Q50506579 |
| | MiR-301b promotes the proliferation, mobility, and epithelial-to-mesenchymal transition of bladder cancer cells by targeting EGR1. | Q50638062 |
| | MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells. | Q51125525 |
| | The polymorphic terminal-loop of pre-miR-1307 binding with MBNL1 contributes to colorectal carcinogenesis via interference with Dicer1 recruitment. | Q53219237 |
| | Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas. | Q53637585 |
| | Role of long non-coding RNA in drug resistance in non-small cell lung cancer. | Q53687949 |
| | An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer. | Q55285194 |
| | FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC | Q58761835 |
| | Downregulation of the long noncoding RNA MBNL1-AS1 protects sevoflurane-pretreated mice against ischemia-reperfusion injury by targeting KCNMA1 | Q58763887 |
| | miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer | Q63253996 |
| | Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma | Q80472901 |
| | Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells | Q86419308 |
| | LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC | Q88381332 |
| | Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial | Q27853359 |
| | miR-544a promotes the invasion of lung cancer cells by targeting cadherina 1 in vitro | Q33734753 |
| | Selective activation of p53-mediated tumour suppression in high-grade tumours | Q34151826 |
| | The microRNA-130/301 family controls vasoconstriction in pulmonary hypertension | Q35002833 |
| | LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis | Q35038732 |
| | Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2. | Q36093282 |
| | Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411. | Q36380909 |
| | MBNL1-RNA recognition: contributions of MBNL1 sequence and RNA conformation | Q37473486 |
| | Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer | Q37640196 |
| | A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer. | Q37877407 |
| | Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer. | Q38761203 |
| | Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line | Q38846641 |
| | Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression | Q38928640 |
| | MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2. | Q38929247 |
| | Targeting Lung Cancer Stem Cells: Research and Clinical Impacts | Q39321673 |
| | Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer | Q39669384 |
| | MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). | Q39728869 |
| | Long non-coding RNA Unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells | Q40491464 |
| | Downregulation of microRNA-301a inhibited proliferation, migration and invasion of non-small cell lung cancer by directly targeting DLC1. | Q42972327 |
| | Increased expression of microRNA-301a in nonsmall-cell lung cancer and its clinical significance | Q44298940 |
| | MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2. | Q47294650 |
| | Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer | Q47794059 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| | limma | Q112236343 |
| | affy | Q113334509 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug resistance | Q12147416 |
| | non-small-cell lung carcinoma | Q3658562 |
| | Proliferation | Q25096177 |
| P304 | page(s) | 144 | |
| P577 | publication date | 2019-05-21 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer | |
| P478 | volume | 10 | |